On March 10, 2020 American Brain Tumor Association (ABTA) reported a new partnership with the Southeastern Brain Tumor Foundation (SBTF) to accelerate brain tumor research (Press release, American Brain Tumor Association, MAR 10, 2020, View Source [SID1234555388]). Through this partnership, the Southeastern Brain Tumor Foundation will invest $50,000 in the ABTA research program to fund one glioblastoma immunotherapy research project. For more than 46 years, the ABTA has served the brain tumor community by funding research and delivering patient programs and services.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"The Southeastern Brain Tumor Foundation is a critical ally in our joint pursuit of eradicating this devastating disease," said Ralph DeVitto, president and chief executive officer of the American Brain Tumor Association. "Collaborative research partnerships significantly strengthen our ability to accelerate brain tumor research and uncover insights that will one day lead to a cure."
With an established and sophisticated mechanism to evaluate and foster brain tumor research, the ABTA has earned recognition as a trusted and committed research conduit for organizations and foundations who aim to advance brain tumor research. Since 1976, the ABTA has awarded more than $32 million in research grants to scientists from around the world to discover more about the causes, effects, diagnosis and treatment of pediatric and adult brain tumors.
The SBTF founded in 1995, with the mission to improve the quality of life for brain tumor patients and their families, has funded more than 46 projects totaling more than $2.5 million.
"Funding brain tumor research is of paramount importance to each member of the SBTF Board," said Geri-Dee Shaffer, executive director of the Southeastern Brain Tumor Foundation. "Expanding our funding reach through this collaborative effort with the ABTA is very exciting. Together we are stronger and together we can do so much to combat this disease."
The Southeastern Brain Tumor Foundation is an important new partner for the ABTA’s research initiatives. The ABTA is grateful to them and other established research collaborators within the brain tumor community, including the Joel A. Gingras, Jr. Memorial Foundation, Uncle Kory Foundation and Humor to Fight the Tumor, among others.